Scarica l'app Stockscreener
2.07
20.08%
-0.52
Pre-mercato:
2.08
0.01
+0.48%
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché JAGX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.59
Aprire:
$2.31
Volume 24 ore:
269.65K
Relative Volume:
2.73
Capitalizzazione di mercato:
$3.96M
Reddito:
$10.48M
Utile/perdita netta:
$-37.74M
Rapporto P/E:
-0.1279
EPS:
-16.1846
Flusso di cassa netto:
$-29.03M
1 W Prestazione:
-1.43%
1M Prestazione:
-13.39%
6M Prestazione:
-90.80%
1 anno Prestazione:
-92.26%
Intervallo 1D:
$2.06
$2.31
Intervallo di 1 settimana:
$2.02
$2.65
Portata 52W:
$1.9301
$35.25
Jaguar Health Inc Stock (JAGX) Company Profile
Nome
Jaguar Health Inc
Settore
Industria
Telefono
415-371-8300
Indirizzo
200 PINE STREET SUITE 400, SAN FRANCISCO, CA
Confronta JAGX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JAGX
Jaguar Health Inc
|
2.07 | 4.96M | 10.48M | -37.74M | -29.03M | -16.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.30 | 101.51B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.97 | 59.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.73 | 56.69B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
652.43 | 39.57B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
309.69 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Jaguar Health Inc Stock (JAGX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-07-07 | Iniziato | Cantor Fitzgerald | Overweight |
| 2017-07-11 | Iniziato | Rodman & Renshaw | Buy |
Jaguar Health Inc Borsa (JAGX) Ultime notizie
Jaguar Health Inc (JAGX) Q2 2025 Earnings Call Highlights: Revenue Surge and Clinical Milestones Amid Financial Challenges - GuruFocus
Jaguar Health Reports Increased Losses Amid Rising Expenses - TipRanks
Jaguar Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Jaguar Health enters sixth ATM amendment with Ladenburg and Lucid - MarketScreener
Jaguar Health Extends Market Offering Agreement - TipRanks
Jaguar Health extends Lucid Capital Markets role in ATM agreement to year-end - Investing.com
Jaguar Health (JAGX) extends ATM manager role to Dec 31, 2025 | JAGX SEC FilingForm 8-K - Stock Titan
Earnings call transcript: Jaguar Health Q2 2025 sees revenue boost, stock tumbles - Investing.com
Transcript : Jaguar Health, Inc., Q2 2025 Earnings Call, Aug 14, 2025 - MarketScreener
Jaguar Health (JAGX) extends ATM manager to Dec 31, 2025, $22.9M raised | JAGX SEC FilingForm 424B5 - Stock Titan
Jaguar Health: Navigating Financial Turbulence Amid Orphan Drug Hopes - AInvest
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue | JAGX Stock News - GuruFocus
Jaguar Health Reports Second Quarter 2025 Financials: Net Q2 2025 Revenue Up Approximately 35% Versus Net Q1 2025 Revenue - ACCESS Newswire
Jaguar Health Earnings Preview: What to Expect - AInvest
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates - Lohud
What’s the recovery path for long term holders of Jaguar Health Inc.Oil Prices & Long-Term Growth Stock Strategies - Newser
Volume spikes in Jaguar Health Inc. stock – what they meanQuarterly Risk Review & Low Risk High Reward Ideas - Newser
Jaguar Health to Host Investor Webcast on Q2 2025 Financials & Corporate Updates - AInvest
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8: - GuruFocus
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates | JAGX Stock News - GuruFocus
Jaguar Health Announces Double Header: Q2 Earnings Call and Emerging Growth Conference Presentation This Week - Stock Titan
Why Jaguar Health Inc. stock attracts strong analyst attentionPositive Outlook Long-Term Picks - sisaissue.com
Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs - Reno Gazette Journal
Jaguar Animal Health (JAGX) Projected to Post Quarterly Earnings on Tuesday - Defense World
Form 424B3Prospectus [Rule 424(b)(3)] - ADVFN Brasil
Jaguar Health JAGX 2025Q2 Earnings Preview Downside Ahead on Recent Economic Developments - AInvest
Can Jaguar Health Inc. sustain its profitabilityLow Float Big Mover Alerts - thegnnews.com
Jaguar Health prices 0.25M shares at $6.09 in registered direct offering - MSN
Jaguar Health Inc expected to post a loss of $7.13 a shareEarnings Preview - TradingView
Visualizing Jaguar Health Inc. stock with heatmapsAI Trade Signal Forecast with Chart Logic - Newser
Jaguar Health Inc. Recovery Hinges on Volume BreakoutMarket Momentum Signal Generator Shows Trends - beatles.ru
Pattern recognition hints at Jaguar Health Inc. upsideAI Triggered Buy Zone Forecast System - Newser
What catalysts could drive Jaguar Health Inc. stock higher in 2025Build wealth faster with expert stock picks - Jammu Links News
What institutional investors are buying Jaguar Health Inc. stockCapitalize on emerging market sectors - Jammu Links News
What are analysts’ price targets for Jaguar Health Inc. in the next 12 monthsBuild a portfolio that outperforms the market - Jammu Links News
How does Jaguar Health Inc. compare to its industry peersHigh-velocity gains - Jammu Links News
Is Jaguar Health Inc. stock overvalued or undervaluedFree Market Volatility Navigation Tips - Jammu Links News
What is Jaguar Health Inc. company’s growth strategyHigh-margin investment plays - Jammu Links News
What analysts say about Jaguar Health Inc. stockInvest confidently with professional market insights - Jammu Links News
Is Jaguar Health Inc. a good long term investmentInvest smarter with daily market updates - Jammu Links News
Why is Jaguar Health Inc. stock attracting strong analyst attentionUnlock powerful market insights for success - Jammu Links News
How volatile is Jaguar Health Inc. stock compared to the marketMaximize returns with strategic stock selection - Jammu Links News
How many analysts rate Jaguar Health Inc. as a “Buy”High-return market picks - Jammu Links News
why is JAGX "Revenue Below Expectations" - AInvest
When is Jaguar Health Inc. stock expected to show significant growthFree Stock Recommendation With Proven Results - Jammu Links News
Is Jaguar Health Inc. a growth stock or a value stockRetirement Planning Target Finder Backed By Experts - Jammu Links News
What makes Jaguar Health Inc. stock price move sharplySmart Money Tracking Signal Generator Activated - metal.it
Can JAGX sustain its Q4 2024 earnings momentum? - AInvest
How did JAGX's Q4 2024 earnings surprise investors? - AInvest
How did JAGX's revenue and expenses shift in Q4 2024? - AInvest
What risks could impact Jaguar Health Inc. stock performanceTriple Digit Return Stock Predictions Released - metal.it
Jaguar Health Inc Azioni (JAGX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.11%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):